跳至主要内容
临床试验/CTRI/2023/10/058191
CTRI/2023/10/058191招募中Unknown

Development of A Generic Blood Diagnostic Methodology Based on Gene Signatures To Investigate Mutational Status Of Hepatocellular Carcinoma Patients - NI

Mohamed Rela0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1. All patients with a diagnosis of hepatocellular carcinoma on imaging
  • 2. All patients with a suspicion of hepatocellular caricnoma based on imaging or tumour markers (elevated AFP, PIVKA)
  • 3. Patients undergoing surgery (resection or transplant) for hepatocellular carcinoma
  • 4. Patients undergoing palliative care modalities (chemotherapy, immunotherapy, embolisation etc) for hepatocellular carcinoma

排除标准

  • 1. Age below 18 years, or above 80 years
  • 2. patients with liver tumors other than hepatocellular carcinoma
  • 3. Patients who refuse to enroll for the study

研究者

发起方
Mohamed Rela

相似试验